[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fgLCnGgdSDmlrENr41Swj4oX68QpDaffbFiR8Khcqwtc":8,"$f0CwPpmXr8HxgkIivINXTbUkP_SevQoSCCw9uWssW2zo":55,"$f7eVZ3iiRqbbHrVs7BJPeZTQ10mglNGT74mISUEBFvzs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65694,869170,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//i3z4Ip4S9vgWeB2cAErxS44yjGkqD3OR.png","杨景帅","东港市第二医院","肿瘤科","主治医师",7,0,"晚期肺癌靶向与支持药品实用指南：安全用药细节一览","","https://cdn.yishi-tong.com/console/store-46/NgJBbherWfjGL5AwR5AsIveL_U6KvBeZ.png","\u003Cdiv class=\"advlc-container\">\n  \u003Ch1 id=\"material_title\" class=\"advlc-title advlc-title-bg\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    晚期肺癌靶向与支持药品实用指南：安全用药细节一览\n  \u003C/h1>\n\n  \u003Cdiv class=\"advlc-intro advlc-section-bg\">\n    \u003Cp>\n      提到靶向治疗和支持用药，许多人关注疗效，其实一点细节也不能忽视。本文专注介绍与“晚期肺癌常用药物”相关的核心知识，包括EGFR-TKI类药物、骨转移抑制剂以及镇痛药物（阿美替尼、奥希替尼、地舒单抗等）。全文涵盖7大方面细致讲解，从剂型选择到储存规范，再到不良反应处理，助您轻松掌握关键用药细节，科学规避风险，让治疗效果更有保障。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型特点和服用技巧 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💉 剂型特点和服用技巧\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI（如阿美替尼、奥希替尼）：\u003C/strong> 多为薄膜包衣片，主要设计用于口服。正确做法：整片吞服，勿掰碎、嚼服，也不要溶解在水中服用，以避免药效变动。\u003Cbr>\n        为什么？片剂表面包膜帮助均匀释放药物，破坏包衣会导致吸收速度异常，影响安全性和疗效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong> 乙状注射液，须由医务人员按月皮下注射，不建议自行操作。\u003Cbr>\n        需要注意：注射前药物保持室温，用前切勿摇晃以防起泡，避免在同一部位连续多次注射。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>镇痛药物（如阿片类口服缓释片）：\u003C/strong> 切忌掰碎和嚼服。正确做法：整片温水吞下，有利于药物缓慢释放，减少骤然高浓度吸收导致的风险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"advlc-case advlc-case-bg\">\n      \u003Cspan class=\"advlc-case-icon\">📌\u003C/span>\n      \u003Cspan class=\"advlc-case-text\">\n        有位患者未按要求整片服用靶向药，导致不良反应加重。正确遵守服药方式能大幅降低风险。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 02 服用时间和具体方法 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⏰ 服用时间和具体方法\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>阿美替尼、奥希替尼等：\u003C/strong> 通常建议每日一次、固定时间口服。可与食物同服，也可空腹服用。建议选择容易记住的时间点，提高依从性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong> 每28天注射1次。坚持定期注射周期，否则药效保护可能间断。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>镇痛类缓释片：\u003C/strong> 应遵循说明书明确的间隔服用（如每12小时1次），不要随意延后或提前。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"advlc-case-icon\">⚠\u003C/span>  \n      \u003Cstrong>特殊提醒：\u003C/strong> 有些药物要求规律服药，随便变换时间会影响体内药浓度，进而影响效果和安全性。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 03 药物作用机制简要说明 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💫 药物作用机制概要\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI：\u003C/strong>（代表药物：阿美替尼、奥希替尼）通过阻断表皮生长因子受体（EGFR）信号，阻止细胞异常增殖，进而发挥作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong> 属于单克隆抗体，阻断RANKL以抑制破骨细胞活性，从而减缓骨转移相关骨质破坏。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>口服镇痛缓释片：\u003C/strong> 通过作用于中枢神经系统的阿片受体，减轻疼痛信号的传递。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan class=\"advlc-case-icon\">🎯\u003C/span>这部分只涉及药理机制，没有具体用法细节。有关服用方式，请参看上面对应部分。\n  \u003C/div>\n  \n  \u003C!-- 04 药物相互作用，日常冲突注意点 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🤠 药物相互作用\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI（如阿美替尼、奥希替尼）：\u003C/strong>\u003Cbr>\n        此类药物代谢依赖肝脏酶（CYP3A4），不能同服强效酶诱导剂（如利福平、卡马西平），否则药效减弱。应避免同服酶抑制剂（如酮康唑等），以防药物血中浓度增高，提高不良反应风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>\u003Cbr>\n        与高钙补剂或维生素D需合理搭配使用。正确做法：定期监测血钙，按需补充，避免引起高钙血症或低钙血症。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿片类镇痛缓释片：\u003C/strong>\u003Cbr>\n        不建议与酒类、安眠药、苯二氮卓类镇静剂一同使用，防止抑制呼吸风险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"advlc-case advlc-case-bg\">\n      \u003Cspan class=\"advlc-case-icon\">📌\u003C/span>\n      \u003Cspan class=\"advlc-case-text\">\n        临床研究显示，当奥希替尼与酶诱导性抗癫痫药一起服用时，其血药浓度可下降近50%。（参考：Soria, J-C. et al., 2018, The New England Journal of Medicine）\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 用药注意事项与用药禁忌 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">✍️ 用药注意事项与用药禁忌\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI（阿美替尼、奥希替尼）：\u003C/strong>\u003Cbr>\n        禁用于对本品成分过敏者。肝肾功能不全者须在医生指导下慎用，高龄患者也应酌情调整剂量。禁止孕妇使用，哺乳期女性应暂停哺乳。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong>\u003Cbr>\n        禁用于严重低钙血症患者。孕妇、哺乳期需权衡利弊后决定是否用药。高龄者须警惕下颌骨坏死等罕见风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿片类镇痛缓释片：\u003C/strong>\u003Cbr>\n        禁用于呼吸抑制、急性哮喘、近期肠梗阻者等。严重肝肾功能衰竭者不用。老年体弱患者须从低剂量用起。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"advlc-case advlc-case-bg\">\n      \u003Cspan class=\"advlc-case-icon\">📌\u003C/span>\n      \u003Cspan class=\"advlc-case-text\">\n        一位老年患者因肾功能轻度下降在用阿美替尼时，医生主动调整剂量，避免了不适反应发生。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应及处理方法 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💊 不良反应及其处理\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI（阿美替尼、奥希替尼）：\u003C/strong> \u003Cbr>\n        常见：皮疹、腹泻、口腔溃疡。\u003Cbr>\n        正确做法：轻度症状多自限，持续或严重时应就医，酌情调整剂量或停药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗：\u003C/strong> \u003Cbr>\n        常见：低血钙、肌肉抽搐。\u003Cbr>\n        处理：检测血钙后按需补充钙剂/维D。！\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿片类镇痛缓释片：\u003C/strong> \u003Cbr>\n        常见：便秘、嗜睡、恶心。\u003Cbr>\n        处理：合理饮食，多饮水，如有剧烈不适须及时复诊。镇静、呼吸抑制需紧急处理。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"advlc-case-icon\">📝\u003C/span>\n      \u003Cstrong>数据表明：\u003C/strong> 奥希替尼常见不良反应总发生率约70%，其中大部分为轻中度，严重反应比例小于10%。\u003Cbr>\n      （参考：Ramalingam, S. S., et al., 2020, New England Journal of Medicine)\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 07 储存条件和有效期管理 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📦 储存条件和有效期管理\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>EGFR-TKI类片剂：\u003C/strong> \u003Cbr>\n        建议密封干燥，避光保存，温度控制在15～30℃。避免儿童接触，药片不得与食物、茶叶等混放。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>地舒单抗注射液：\u003C/strong> \u003Cbr>\n        保持在2～8℃冷藏，切勿冷冻。开封后需在规定时间内用完。运输中避免剧烈震动。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>缓释镇痛药：\u003C/strong> \u003Cbr>\n        妥善保存于原药瓶，避免潮湿和阳光直射，勿与其他药物混装。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"advlc-case-icon\">⏱\u003C/span>  \n      \u003Cstrong>正确做法：\u003C/strong> 过期药品需及时送回药店或医院统一回收，切勿自行丢弃。\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 08 漏服与剂量调整，过量处理 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⚡ 漏服与过量应对\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cul>\n      \u003Cli>\n        \u003Cstrong>漏服EGFR-TKI：\u003C/strong> 想起补服时距离下次服药已近，则跳过本次。不可同时服两次，也不可随意加量补救。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服地舒单抗：\u003C/strong> 尽快联系医务人员补打，不要自行加快注射进程。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>阿片类药品多服：\u003C/strong> 若疑服用过量，有明显嗜睡、呼吸缓慢等异常需立即就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"advlc-case advlc-case-bg\">\n      \u003Cspan class=\"advlc-case-icon\">📌\u003C/span>\n      \u003Cspan class=\"advlc-case-text\">\n        有患者一次漏服镇痛缓释片，未擅自补服，仅维持下次按时服药，未见副作用。\n      \u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 总结重申 -->\n  \u003Ch2 class=\"advlc-subtitle advlc-section-bg advlc-icon-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🎯 总结与安全用药提醒\u003C/h2>\n  \u003Cdiv class=\"advlc-content advlc-section-bg\">\n    \u003Cp>\n      药物的使用细节直接关系到治疗效果和用药安全。根据国际指南和真实用药案例，推荐牢牢记住这几点：\u003Cbr>\n      \u003Cstrong>第一，药品服用方法不得随意变动，特别是靶向口服片和缓释片必须整片吞服；\u003C/strong>\u003Cbr>\n      \u003Cstrong>第二，按周期规律服药或注射，切莫自己调整间隔；\u003C/strong>\u003Cbr>\n      \u003Cstrong>第三，如用药过程中发现异常反应（如持续腹泻、明显嗜睡、抽搐、注射部位红肿等），应及时联系医务人员处理。\u003C/strong>\n    \u003C/p>\n    \u003Cp>安全用药，始终将规范和细节放在首位。遇到疑问，一定要与医生或药师沟通。规范用药，让药物成为真正的好帮手。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 文献引用列表 -->\n  \u003Cdiv class=\"advlc-ref-title advlc-section-bg advlc-icon-title\">📚 参考文献\u003C/div>\n  \u003Col class=\"advlc-ref-list advlc-section-bg\">\n    \u003Cli>\n      Soria, J.-C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., ... & Ramalingam, S. S. (2018). Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 378(2), 113-125.\n    \u003C/li>\n    \u003Cli>\n      Ramalingam, S. S., Vansteenkiste, J., Planchard, D., Cho, B. C., Gray, J. E., Ohe, Y., ... & Soria, J.-C. (2020). Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. \u003Cem>New England Journal of Medicine\u003C/em>, 382(1), 41-50.\n    \u003C/li>\n    \u003Cli>\n      Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Brown, J. E., Yardley, D. A., ... & Jun, S. (2012). Superiority of denosumab to zoledronic acid for preventing skeletal-related events: a combined analysis of 3 pivotal, randomized, phase 3 trials. \u003Cem>European Journal of Cancer\u003C/em>, 48(6), 1017-1025.\n    \u003C/li>\n    \u003Cli>\n      Palliative Care Formulary Editorial Team. (2020). Opioid analgesics. \u003Cem>Palliative Care Formulary (PCF6)\u003C/em>. Pharmaceutical Press.\n    \u003C/li>\n  \u003C/ol>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立专用样式，前缀 advlc- 避免全局污染 */\n.advlc-container {\n  max-width: 830px;\n  background-color: #fdfcfb;\n  margin: 30px auto;\n  border-radius: 18px;\n  padding: 30px 36px 38px 36px;\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  color: #2b2d31;\n  box-shadow: 0 8px 32px rgba(212,212,220,0.22);\n}\n.advlc-title {\n  font-size: 2.3em;\n  font-weight: bold;\n  padding: 30px 20px 22px 20px;\n  margin-bottom: 29px;\n  border-radius: 11px;\n  line-height: 1.25em;\n  letter-spacing: 0.5px;\n  background: linear-gradient(93deg, #dbeafe 0%, #e5e7eb 100%);\n  text-align: center;\n  border: 2px solid #b6cbde;\n}\n.advlc-subtitle {\n  font-size: 1.3em;\n  font-weight: 600;\n  color: #22509e;\n  margin-top: 38px;\n  margin-bottom: 15px;\n  padding: 19px 28px 16px 28px;\n  border-radius: 8px 8px 0 0;\n  background: linear-gradient(93deg, #e7f6fe 0%, #f5f5fe 100%);\n  border-left: 7px solid #b1d3f6;\n  position: relative;\n}\n.advlc-section-bg {\n  background: linear-gradient(92deg,#f5f8fa 0%, #f4f7fd 100%);\n}\n.advlc-content {\n  margin-bottom: 15px;\n  padding: 22px 28px 20px 28px;\n  border-radius: 0 0 7px 7px;\n  border: 1px solid #e5e9f3;\n  border-top: none;\n  font-size: 1.04em;\n  letter-spacing: 0.16px;\n}\n.advlc-intro {\n  border-left: 5px solid #b1d1f9;\n  margin-bottom: 26px;\n  font-size: 1.12em;\n  padding: 19px 24px 17px 24px;\n  background: linear-gradient(93deg, #eef3fa 0%, #f7fafc 100%);\n  border-radius: 10px;\n}\n.advlc-icon-title {\n  display: flex;\n  align-items: center;\n  gap: 9px;\n}\n.advlc-references {\n  font-size: 0.98em;\n  line-height: 1.62em;\n}\n.advlc-ref-title {\n  font-size: 1.15em;\n  color: #0d3f69;\n  font-weight: 600;\n  margin-top: 41px;\n  margin-bottom: 5px;\n  padding: 17px 26px 16px 26px;\n  border-radius: 10px 10px 0 0;\n  border-left: 7px solid #b8d3fe;\n  background: linear-gradient(93deg, #e3f3ff 0%, #faffe7 100%);\n}\n.advlc-ref-list {\n  border: 1px solid #e4ecfa;\n  border-radius: 0 0 7px 7px;\n  padding: 19px 32px 12px 36px;\n  background: #f5fafd;\n  font-size: 1.01em;\n  color: #3b4250;\n  margin-bottom: 0px;\n  margin-top: 0px;\n}\n.advlc-case {\n  display: flex;\n  align-items: center;\n  background: linear-gradient(91deg, #fffbf0 0%, #f7faff 100%);\n  border-left: 5px solid #ffe09c;\n  border-radius: 6px;\n  padding: 16px 29px;\n  margin-top: 15px;\n  font-size: 1.02em;\n  box-shadow: 0 2px 8px rgba(245, 236, 188, 0.12);\n}\n.advlc-case-icon {\n  font-size: 1.07em;\n  margin-right: 8px;\n}\n.advlc-case-text {\n  flex: 1;\n}\n.advlc-case-bg {\n  background: linear-gradient(90deg,#fffbe6 10%, #f1fbfe 100%);\n  border-left: 4px solid #ffeb9c;\n}\nul {\n  margin-top: 0.35em;\n  margin-bottom: 0.9em;\n  padding-left: 2.2em;\n}\nol {\n  margin-bottom: 0.6em;\n}\nli {\n  margin-bottom: 0.5em;\n  line-height: 1.8em;\n}\nem {\n  font-style: italic;\n}\nstrong {\n  color: #2857a3;\n  font-weight: 600;\n}\n\u003C/style>\n\n","\u003Cdiv class=\"advlc-container\">\n  \u003Ch1 id=\"material_title\" class=\"advlc-title advlc-title-bg\" style=\"co",503,"2025-09-04 15:02:29","晚期肺癌, 靶向治疗, EGFR-TKI, 药物不良反应, 安全用药, 镇痛药, 用药注意事项, 膜衣药片, 地舒单抗","掌握晚期肺癌治疗核心药物的用药细节，避免不良反应，确保疗效！本指南涵盖靶向药物、镇痛剂的使用方法和注意事项，适用于患者及家属。","2025-09-08 11:10:27",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]